Skip to main content
. 2013 Nov 27;15(1):47–57. doi: 10.1111/papr.12146

Figure 2.

Figure 2

Time to onset and resolution of common adverse events in studies of flexible-dose pregabalin. Kaplan–Meier plots of (A) time to onset and (B) time to resolution of common adverse events (those with a risk difference > 3) in the pregabalin flexible-dose group. Data followed similar trends for other doses of pregabalin and for placebo, for both time to onset and time to resolution.